23 results on '"Majer, I."'
Search Results
2. PCR117 Meaningful Change Thresholds in Patient-Reported Outcome Scores for Patients with Colorectal Cancer – A Systematic Literature Review
3. EE155 Burden of Illness of Adult Patients with Metastatic Colorectal Cancer Bearing the KRAS P.G12C Mutation - A Systematic Literature Review
4. HEALTH CARE RESOURCE USE AND COST IN RHEUMATOID ARTHRITIS PATIENTS ASSOCIATED WITH DIFFERENT BDMARD TREATMENT LINES: A GERMAN CLAIMS DATA ANALYSIS BASED ON 3624 PATIENTS
5. Cost-Effectiveness of Palivizumab In Children With Congenital Heart Disease In Mexico
6. Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico
7. A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Prostate Cancer Patients With non-Visceral Metastases
8. Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Chemotherapy Naïve Patients
9. PMS44 - HEALTH CARE RESOURCE USE AND COST IN RHEUMATOID ARTHRITIS PATIENTS ASSOCIATED WITH DIFFERENT BDMARD TREATMENT LINES: A GERMAN CLAIMS DATA ANALYSIS BASED ON 3624 PATIENTS
10. A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis
11. PCN93 - A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Prostate Cancer Patients With non-Visceral Metastases
12. PIH13 - Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico
13. PCV18 - Cost-Effectiveness of Palivizumab In Children With Congenital Heart Disease In Mexico
14. PCV16 HEALTH INSURANCE COSTS OF STROKE HOSPITAL TREATMENTS IN HUNGARY; 2003-2005
15. PDB41 EFFECT OF COMPLICATIONS ON HEALTH RELATED QUALITY OF LIFE IN HUNGARIAN INSULIN TREATED DIABETIC PATINETS
16. PCN12 - Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Chemotherapy Naïve Patients
17. PMS48 - A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis
18. PAR17 BURDEN OF ILLNESS, COSTS AND OUTCOMES OF RHEUMATOID ARTHRITIS IN HUNGARY
19. PMS48 A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis
20. PCN93 A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Prostate Cancer Patients With non-Visceral Metastases
21. PIH13 Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico
22. PCV18 Cost-Effectiveness of Palivizumab In Children With Congenital Heart Disease In Mexico
23. PCN12 Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Chemotherapy Naïve Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.